Boxer Asset Management Inc.
CIK 1465836 · last filed 2021-12-21
Boxer Asset Management Inc. is a corporate insider who has filed 7 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing shows the insider bought $4.9M of TYRA on Dec 21, 2021. Across all open-market trades the lifetime net is +$27.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $184.7M across reported positions. The firm reports its address in Lyford Cay, New Providence, C5. 63 SEC filings were submitted jointly with Boxer Capital, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$184.75M
4
7
$27.44M
Filer Profile
EP TAYLOR DRIVE N7776
LYFORD CAY, NEW PROVIDENCE, C5 00000
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TYRA | 10%+ Owner | 6,448,359 | $28.65 | $184.75M | $4.92M | 1 | 2021-12-21 |
| Odonate Therapeutics, Inc. (ODT) Delisted | 10%+ Owner | 4,910,786 | $1.12 | $5.50M | $16.93M | 2 | 2020-09-09 |
| Esperion Therapeutics, Inc. (ESPR) Delisted | 10%+ Owner | 1,134,750 | $3.18 | $3.61M | -$16.92M | 1 | 2018-11-05 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 2,323,495 | $58.70 | $136.39M | $22.50M | 3 | 2018-06-11 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-21 | TYRA | Buy (P) | +375,000 | $4.92M | EDGAR |
| 2020-09-09 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +675,000 | $10.11M | EDGAR |
| 2018-11-05 | Esperion Therapeutics, Inc. (ESPR) Delisted | Sell (S) | −300,000 | -$16.92M | EDGAR |
| 2018-06-11 | Mirati Therapeutics, Inc. (MRTX) Delisted | Buy (P) | +579,150 | $22.50M | EDGAR |
| 2018-03-26 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +300,000 | $6.82M | EDGAR |
| 2016-03-17 | Mirati Therapeutics, Inc. (MRTX) Delisted | Other (J) | −375,298 | $0 | EDGAR |
| 2016-01-15 | Mirati Therapeutics, Inc. (MRTX) Delisted | Other (J) | −626,189 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.